Every year, millions of people survive a stroke only to face an uncertain recovery — and medicine has long struggled to explain why outcomes vary so widely. A research team in Croatia has now looked inside the clots themselves, using metabolomics to read the molecular language written in retrieved thrombi and patient blood. What they found suggests that a stroke unfolds as two simultaneous biochemical stories: one systemic, one intensely local — and that understanding both may be the key to predicting who recovers and who does not.
Metabolomics Study Maps Distinct Biochemical Signatures in Ischemic Stroke Thrombi
Ischemic stroke causes significant mortality and long-term disability, affecting millions globally with variable outcomes despite current reperfusion therapies.
Culture & Arts